ACAAW Averin Capital Acquisition Corp.
Price Chart
Executive Summary
Averin Capital Acquisition Corp. appointed Akiko Moni Miyashita, age 70, to its board of directors effective May 28, 2026. Ms. Miyashita brings experience in strategy, M&A, and healthcare/life sciences. She also filed a Form 3 initial statement of beneficial ownership reporting zero securities owned. This is a routine board appointment for a SPAC seeking a business combination.
Actionable Insight
Monitor for any future business combination announcement from this SPAC. The addition of a director with M&A and healthcare expertise may signal the target sector, but no deal catalyst is present here.
Key Facts
- Akiko Moni Miyashita appointed to the board of directors effective May 28, 2026.
- Ms. Miyashita is the Founder of Beacon Hill Strategy Group and previously served on the board of Halozyme Therapeutics.
- She signed joinders to the Letter Agreement and Registration Rights Agreement dated February 18, 2026, agreeing to waive certain redemption rights and vote in favor of an initial business combination.
- Form 3 filed concurrently reports zero securities owned by Ms. Miyashita in the issuer.
- No family relationships or material transactions with the company were disclosed.
Financial Impact
No financial impact — routine board appointment with no compensation or financial terms disclosed.
Risk Factors
- SPAC may fail to identify a suitable target before its deadline, leading to liquidation.
- No financial or operational data provided — the filing is purely administrative.
Market Snapshot
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (ACAAW) — Batch item 1 | 0001213900-26-062861 |
| Document: 0001213900-26-062861-index.html | 0001213900-26-062863 |
| Document: 0001213900-26-062861.txt | 0001213900-26-062861 |
| 8-K Filing (ACAAW) — Batch item 4 | 0001213900-26-062863 |
| Document: 0001213900-26-062863-index-headers.html | 0001213900-26-062861 |
| Document: 0001213900-26-062863-index.html | 0001213900-26-062861 |
| Document: 0001213900-26-062863.txt | 0001213900-26-062861 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access